Clinical Trials Logo

Tibial Plateau Fracture clinical trials

View clinical trials related to Tibial Plateau Fracture.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04639011 Withdrawn - Pain, Postoperative Clinical Trials

Duloxetine Tibial Plateau

Start date: October 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if Duloxetine provides effective pain management for adult patients (18 or older) undergoing tibial plateau surgery. Participants from two institutions will be randomized to one of two treatment groups: control (Group A) and treatment (Group B). Group A control group will receive placebo of sugar pill and BMC standard of care - namely postoperative, IV administration of opioids via a patient controlled analgesia (PCA) system which utilizes a hydromorphone pump (BMC standard of care). Group B, the intervention group, will receive three doses of 60 mg of oral duloxetine (right before operation, postop day 1, postop day 2). This study is important as tibial plateau surgery's postoperative pain management primarily involved providing opioids, and if duloxetine can result in reduced narcotic intake and lower pain scores, it can potentially improve patient care, rehabilitation, early movement, and shorter length of hospital stay.